The Drug Enforcement Administration’s (DEA’s) National Forensic Laboratory Information System (NFLIS) is pleased to release the NFLIS-Drug Snapshot: December...
Reports
NDEWS Hotspot Alerts March 2 – 8, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 27 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
The Rapid Street Reporting (RSR) team visited Charlotte, NC on February 24–26, 2023 as the third RSR Hotspot location....
Federal Register Notice of Proposed Rule: Expansion of Induction of Buprenorphine via Telemedicine Encounter
Lisa McElhaney / /SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations, in concert with the Department of Health and Human...
Learn more about the current distribution of naloxone in the U.S. and the potential economic impacts of a change...
Health Care and Public Health Sector Cybersecurity Framework Implementation Guide
Lisa McElhaney / /The U.S. Department of Health and Human Services (HHS), through the Administration for Strategic Preparedness and Response (ASPR), released...
The Drug Enforcement Administration will permanently place brorphine in Schedule I of the Controlled Substances Act, effective April 5,...
NDEWS Hotspot Alerts February 23 – March 1, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 31 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day...
Federal Register Notice of Proposed Rule: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In- Person Medical Evaluation
Lisa McElhaney / /SUMMARY: Under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and Drug Enforcement Administration’s (DEA) implementing regulations, after a patient and...
The report includes a snapshot of recent drug and fentanyl co-positivity trends, perspectives on fentanyl analogs, and an overview...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024